147 related articles for article (PubMed ID: 11725181)
21. Recoverin-associated retinopathy: a clinically and immunologically distinctive disease.
Whitcup SM; Vistica BP; Milam AH; Nussenblatt RB; Gery I
Am J Ophthalmol; 1998 Aug; 126(2):230-7. PubMed ID: 9727517
[TBL] [Abstract][Full Text] [Related]
22. Anti-alpha-enolase antibodies in cancer-associated retinopathy with small cell carcinoma of the lung.
Dot C; Guigay J; Adamus G
Am J Ophthalmol; 2005 Apr; 139(4):746-7. PubMed ID: 15808190
[TBL] [Abstract][Full Text] [Related]
23. Acute progressive paravascular placoid neuroretinopathy with negative-type electroretinography in paraneoplastic retinopathy.
Chen FK; Chew AL; Zhang D; Chen SC; Chelva E; Chandrasekera E; Koay EMH; Forrester J; McLenachan S
Doc Ophthalmol; 2017 Jun; 134(3):227-235. PubMed ID: 28382556
[TBL] [Abstract][Full Text] [Related]
24. Paraneoplastic retinopathy associated with antiretinal bipolar cell antibodies in cutaneous malignant melanoma.
Weinstein JM; Kelman SE; Bresnick GH; Kornguth SE
Ophthalmology; 1994 Jul; 101(7):1236-43. PubMed ID: 8035987
[TBL] [Abstract][Full Text] [Related]
25. [Paraneoplastic retinopathy and optic neuropathy].
Ikawa M; Kuriyama M
Brain Nerve; 2010 Apr; 62(4):371-6. PubMed ID: 20420177
[TBL] [Abstract][Full Text] [Related]
26. Bilateral diffuse uveal melanocytic proliferation in a patient with cancer-associated retinopathy.
Saito W; Kase S; Yoshida K; Ohguro H; Yokoi M; Iwaki H; Ohno S
Am J Ophthalmol; 2005 Nov; 140(5):942-5. PubMed ID: 16310487
[TBL] [Abstract][Full Text] [Related]
27. Latest updates on antiretinal autoantibodies associated with vision loss and breast cancer.
Adamus G
Invest Ophthalmol Vis Sci; 2015 Mar; 56(3):1680-8. PubMed ID: 25754855
[TBL] [Abstract][Full Text] [Related]
28. Antibody reactions with retina and cancer-associated antigens in 10 patients with cancer-associated retinopathy.
Thirkill CE; Keltner JL; Tyler NK; Roth AM
Arch Ophthalmol; 1993 Jul; 111(7):931-7. PubMed ID: 8392327
[TBL] [Abstract][Full Text] [Related]
29. [Paraneoplastic retinopathy in 2 patients with breast carcinoma].
Huober J; Holz FG; Schmid H; Nölle B; Bellmann C; Krastel H; Wallwiener D; Bastert G
Zentralbl Gynakol; 1997; 119(6):278-81. PubMed ID: 9312964
[TBL] [Abstract][Full Text] [Related]
30. Autoantibodies to photoreceptor membrane proteins and outer plexiform layer in patients with cancer-associated retinopathy.
Peek R; Dijkstra BG; Meek B; Kuijpers RW
Clin Exp Immunol; 2002 Jun; 128(3):498-503. PubMed ID: 12067305
[TBL] [Abstract][Full Text] [Related]
31. Incidence of antiretinal antibodies in melanoma: screening of 77 serum samples from 51 patients with American Joint Committee on Cancer stage I-IV.
Ladewig G; Reinhold U; Thirkill CE; Kerber A; Tilgen W; Pföhler C
Br J Dermatol; 2005 May; 152(5):931-8. PubMed ID: 15888149
[TBL] [Abstract][Full Text] [Related]
32. [Severe visual loss caused by autoimmune retinopathy].
ten Berge JC; Schreurs MW; Dufour-van den Goorbergh BC; de Witte PM; van Schooneveld MJ; Rothova A
Ned Tijdschr Geneeskd; 2015; 159():A8039. PubMed ID: 25654680
[TBL] [Abstract][Full Text] [Related]
33. Cancer-associated retinopathy (CAR syndrome) with antibodies reacting with retinal, optic-nerve, and cancer cells.
Thirkill CE; FitzGerald P; Sergott RC; Roth AM; Tyler NK; Keltner JL
N Engl J Med; 1989 Dec; 321(23):1589-94. PubMed ID: 2555714
[No Abstract] [Full Text] [Related]
34. Identification of autoantibodies against TRPM1 in patients with paraneoplastic retinopathy associated with ON bipolar cell dysfunction.
Kondo M; Sanuki R; Ueno S; Nishizawa Y; Hashimoto N; Ohguro H; Yamamoto S; Machida S; Terasaki H; Adamus G; Furukawa T
PLoS One; 2011; 6(5):e19911. PubMed ID: 21611200
[TBL] [Abstract][Full Text] [Related]
35. Cancer-associated retinopathy vs recoverin-associated retinopathy.
Keltner JL; Thirkill CE
Am J Ophthalmol; 1998 Aug; 126(2):296-302. PubMed ID: 9727525
[No Abstract] [Full Text] [Related]
36. Cone dysfunction as a paraneoplastic syndrome associated with retinal antigens approximating 40 kiloDalton.
Parc CE; Azan E; Bonnel S; Sahel JA; Kaplan J; Thirkill CE
Ophthalmic Genet; 2006 Jun; 27(2):57-61. PubMed ID: 16754207
[TBL] [Abstract][Full Text] [Related]
37. Treatment of paraneoplastic visual loss with intravenous immunoglobulin: report of 3 cases.
Guy J; Aptsiauri N
Arch Ophthalmol; 1999 Apr; 117(4):471-7. PubMed ID: 10206574
[TBL] [Abstract][Full Text] [Related]
38. Role of anti-recoverin autoantibodies in cancer-associated retinopathy.
Adamus G; Guy J; Schmied JL; Arendt A; Hargrave PA
Invest Ophthalmol Vis Sci; 1993 Aug; 34(9):2626-33. PubMed ID: 7688357
[TBL] [Abstract][Full Text] [Related]
39. Immune-mediated retinopathy in a patient with stiff-man syndrome.
Steffen H; Menger N; Richter W; Nölle B; Krastel H; Stayer C; Kolling GH; Wässle H; Meinck HM
Graefes Arch Clin Exp Ophthalmol; 1999 Mar; 237(3):212-9. PubMed ID: 10090584
[TBL] [Abstract][Full Text] [Related]
40. Anti-retinal pigment epithelium antibodies in acute exudative polymorphous vitelliform maculopathy: a new hypothesis about disease pathogenesis.
Koreen L; He SX; Johnson MW; Hackel RE; Khan NW; Heckenlively JR
Arch Ophthalmol; 2011 Jan; 129(1):23-9. PubMed ID: 21220625
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
